Refine by
Metabolic Health Articles & Analysis
17 news found
Creative Proteomics, a leader in proteomics and metabolomics services, has officially launched its innovative Central Carbon Metabolism (CCM) Analysis Service, designed to transform the study of cellular energy dynamics and metabolic pathways in both health and disease. ...
” Lifespin is working to build new precision medicine tools based on quantitative metabolic profiles and proprietary algorithms to assist in the early detection of diseases and monitoring the efficacy of health treatments. ...
The concept of ‘One Health’ recognises that the health of humans, animals, and the environment are intimately interconnected, and that the application of technologies to solve in one domain can inspire and enable advances in others. ...
Leveraging Lifespin’s Comprehensive Metabolic Database Lifespin has built one of the largest and most comprehensive databases of metabolic health profiles across healthy and diseased individuals covering multiple age and gender groups as well as specific diseases in neurology, oncology, and inflammation. ...
New Calibration Tubes, in Three Sizes, Will Simplify Gastric and Bariatric Procedures Including Laparoscopic Sleeve Gastrectomy, Gastric Bypass and Gastric Banding Company to Introduce Product at IFSO 2022 World Congress in August; Sales to Commence in September ReShape Lifesciences (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health ...
ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that its Board of Directors has appointed Paul F. ...
” About Revita® Fractyl Health’s lead product candidate, Revita, is based on the company’s insights surrounding the potential role of the gut in metabolic diseases. ...
” About Revita® Fractyl Health’s lead product candidate, Revita, is based on the company’s insights surrounding the potential role of the gut in metabolic diseases. ...
” About Revita® Fractyl Health’s lead product candidate, Revita, is based on the company’s insights surrounding the potential role of the gut in metabolic diseases. ...
The product, Modius, claims to stimulate the part of the brain that controls fat storage and metabolism. The company, Modius Health, was set up by neuroscientist Dr Jason McKeown from Portglenone, County Antrim in 2013. ...
LEXINGTON, Mass., November 30, 2021 – Fractyl Health, an organ-editing metabolic therapeutics company focused on pioneering a new approach to the treatment of type 2 diabetes (T2D), announced today the United States Food and Drug Administration’s (FDA’s) authorization to expand its Revitalize-1 pivotal clinical study (formerly known as ...
LEXINGTON, Mass., October 27, 2021 – Fractyl Health, a life sciences company dedicated to developing novel therapeutic interventions aimed at reversing the metabolic disease epidemic, including type 2 diabetes (T2D), today announced the publication of an innovative new model of metabolism, the Metabolic Balance Model. ...
Additionally, all treated patients showed significant improvements in measures of glucose regulation and metabolic health. “Eliminating the need for daily insulin could transform disease management for the hundreds of millions of people across the world suffering from type 2 diabetes. ...
” More than 460 million people live with diabetes, according to the International Diabetes Federation, although not all have been diagnosed. A 2016 study by the World Health Organization found the metabolic disorder was the seventh most common cause of death, above road injury. ...
In addition, he served at Boehringer Ingelheim, a pharmaceutical company, as Country Managing Director of UK and Ireland from 2015 to 2017, as Chief Medical Officer from 2010 to 2015, as Corporate Vice President of Medical Affairs from 2008 to 2009, and as Vice President of Therapeutic Area Metabolic Diseases from 2006 to 2008. His responsibilities at Boehringer Ingelheim ...
The award, which includes funding and cutting-edge solutions from Agilent, will enhance his efforts to elucidate the role of the gut microbiome and its metabolic products in health and disease. Dr. Gordon and his colleagues have characterized a program of assembly within the gut microbial community that begins at birth and is largely completed several years ...
'According to the study the glutathione S-transferases act to inactivate chemicals so people without these GSTM1 and GSTT1 genes are less able to metabolize environmental chemicals,” said Lourdes Salvador, Founder and President of MCS America. “If a person cannot metabolize chemicals they build up in the body and cause disturbances in normal body function,” added ...